Advertisement

Current Oral Health Reports

, Volume 4, Issue 2, pp 59–63 | Cite as

The Influence of Periodontal Burden on Metabolic Control of Diabetes—Myth or Reality?—from a Nutritional Perspective

  • Fusanori NishimuraEmail author
  • Tomomi Sano
  • Terukazu Sanui
Oral Disease and Nutrition (F Nishimura, Section Editor)
  • 52 Downloads
Part of the following topical collections:
  1. Topical Collection on Oral Disease and Nutrition

Abstract

Purpose of Review

The effects of periodontal treatment on the metabolic control of diabetes have been extensively studied. This report summarizes current understanding on the underlying mechanisms.

Recent Findings

All recent studies supporting the beneficial effects of periodontal treatment have common features: (1) clinically, periodontal disease in diabetics is relatively severe, (2) the subjects exhibit elevated hs-CRP level, which declines following periodontal treatment, and (3) the subjects generally do not exhibit morbid obesity. Nevertheless, the subjects with higher hs-CRP appear to develop more mature adipose tissues than the subjects with lower hs-CRP.

Summary

Inflammatory immune cells have been reported to migrate into adipose tissue, interact with adipocytes, and thereby exacerbate adipose tissue inflammation. This may be a key mechanism explaining how local periodontal inflammation influences systemic inflammation. Therefore, appropriate life style intervention is an additional requirement in addition to reducing other obvious risk factors such as smoking in the overall management of periodontal disease in subjects with diabetes.

Keywords

Periodontal disease Diabetes Adipocyte-macrophage interaction Low-grade inflammation Life style intervention 

Notes

Compliance with Ethical Standards

Conflict of Interest

All authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

Hiroshima study described in the article was approved by the appropriate Ethical Committee and Informed Consent was already obtained from the participants, and the study was registered in clinical trial registry (UMIN000006356).

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Katagiri S, Nitta H, Nagasawa T, Uchimura I, Izumiyama H, Inagaki K, et al. Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease. Diab Res Clin Pract. 2009;83(3):308–15.CrossRefGoogle Scholar
  2. 2.
    Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, Qin GM. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Intern Med. 2011;50(15):1569–74.CrossRefPubMedGoogle Scholar
  3. 3.
    •• Munenaga Y, Hiroshima Study Group, Yamashina T, Tanaka J, Nishimura F. Improvement of glycated hemoglobin in Japanese subjects with type 2 diabetes by resolution of periodontal inflammation using adjunct topical antibiotics: results from Hiroshima study. Diab Res Clin Pract. 2013;100(1):53–60. Based on the sub-analysis of this study, it was revealed that the subjects with high hs-CRP exhibited higher BMI as compared with the subjects with low hs-CRP among the subjects with diabetes accompanied by severe periodontitis. CrossRefGoogle Scholar
  4. 4.
    Kaur PK, Narula SC, Rajput R, K Sharma R, Tewari S. Periodontal and glycemic effects of nonsurgical periodontal therapy in patients with type 2 diabetes stratified by baseline HbA1c. J Oral Sci. 2015;57(3):201–11.CrossRefPubMedGoogle Scholar
  5. 5.
    • Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, et al. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA. 2013;310(23):2523–32. This trial was a largest randomize clinical trial investigated the effects of periodontal treatment on the metabolic control of diabetes. But the subjects’ average BMI was extremely high. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S. Relationship between periodontal disease and c-reactive protein among adults in the atherosclerosis risk in communities study. Arch Intern Med. 2003;163(10):1172–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Geisinger ML, Michalowicz BS, Hou W, Schoenfeld E, Gelato M, Engebretson SP, et al. Systemic inflammatory biomarkers and their association with periodontal and diabetes-related factors in the diabetes and periodontal therapy trial, a randomized controlled trial. J Periodontol. 2016;87(8):900–13.CrossRefPubMedGoogle Scholar
  8. 8.
    Chen L, Luo G, Xuan D, Wei B, Liu F, Li J, Zhang J. Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study. J Periodontol. 2012;83(4):435–43.CrossRefPubMedGoogle Scholar
  9. 9.
    •• Borgnakke WS, Chapple IL, Genco RJ, Armitage G, Bartold PM, D'Aiuto F, et al. The multi-center randomized controlled trial (RCT) published by the Journal of the American Medical Association (JAMA) on the effect of periodontal therapy on glycated hemoglobin (HbA1c) had fundamental problems. J Evid Based Dent Pract. 2014;14(3):127–32. This review clearly pointed out the problems of DPTT study published in JAMA. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol. 2008;28(7):1385–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Yamashita A, Soga Y, Iwamoto Y, Yoshizawa S, Iwata H, Kokeguchi S, et al. Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide. Obesity. 2007;15(11):2549–52.CrossRefPubMedGoogle Scholar
  12. 12.
    Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015–25.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Yamashita A, Soga Y, Iwamoto Y, Asano T, Li Y, Abiko Y, Nishimura F. DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin. Int J Obese. 2008;32(11):1725–9.CrossRefGoogle Scholar
  14. 14.
    Nakarai H, Yamashita A, Nagayasu S, Iwashita M, Kumamoto S, Ohyama H, et al. Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications. Innate Immun. 2012;18(1):164–70.CrossRefPubMedGoogle Scholar
  15. 15.
    Sano T, Iwashita M, Nagayasu S, Yamashita A, Shinjo T, Hashikata A, et al. Protection from diet-induced obesity and insulin resistance in mice lacking CCL19-CCR7 signaling. Obesity. 2015;23(7):1460–71.CrossRefPubMedGoogle Scholar
  16. 16.
    Shinjo T, Iwashita M, Yamashita A, Sano T, Tsuruta M, Matsunaga H, et al. IL-17A synergistically enhances TNF-a-induced IL-6 and CCL20 production in 3T3-L1 adipocytes. Biochem Biophys Res Com. 2016;477(2):241–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Festa A, Hanley AJ, Tracy RP, D'Agostino Jr R, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation. 2003;108(15):1822–30.CrossRefPubMedGoogle Scholar
  18. 18.
    Demmer RT, Desvarieux M, Holtfreter B, Jacobs Jr DR, Wallaschofski H, Nauck M, et al. Periodontal status and A1c change: longitudinal results from the study of health in Pomerania (SHIP). Diabetes Care. 2010;33(5):1037–43.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and the risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327–34.CrossRefPubMedGoogle Scholar
  20. 20.
    Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, et al. Elevated c-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama study. Diabetes Care. 2005;28(10):2497–500.CrossRefPubMedGoogle Scholar
  21. 21.
    Demmer RT, Squillaro A, Papapanou PN, Rosenbaum M, Friedewald WT, Jacobs Jr DR, Desvarieux M. Periodontal infection, systemic inflammation, and insulin resistance: results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care. 2012;35(11):2235–42.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Fusanori Nishimura
    • 1
    Email author
  • Tomomi Sano
    • 1
  • Terukazu Sanui
    • 1
  1. 1.Section of Periodontology, Department of Oral RehabilitationKyushu University Faculty of Dental ScienceFukuokaJapan

Personalised recommendations